The first Conference on Brain Health Services for the Prevention of Cognitive Impairment and Dementia was held in Geneva in February 2024. In these second-generation memory clinics, cognitively unimpaired persons are assessed for their risk of developing cognitive impairment or dementia, are communicated their risk level, and receive interventions to reduce risk of impairment or even enhance their cognitive performance1. The results of the conference was a document outlining the challenges and opportunities to their implementation in the clinic2.
ICOPAD26 is the continuation of this effort and will convene those experts who are developing programs to deliver these interventions in clinical practice. Participants will learn about the conceptual framework underlying the notions of risk assessment, risk communication, risk reduction, and cognitive enhancement in cognitively unimpaired persons. They will also hear the experience of early adopters and how the concept is being implemented in the clinic, including the use of blood biomarkers, lifestyle interventions, and amyloid lowering and other prevention strategies. A workshop among early adopters (by invitation only) will close the event.
Usefuls readings
- Frisoni GB, Altomare D, Ribaldi F, Villain N, Brayne C, Mukadam N, et al. Dementia prevention in memory clinics: recommendations from the European task force for brain health services. Lancet Reg Health Eur. 2023;26:100576.
- Frisoni GB, Ribaldi F, Allali G, Birth T, Brioschi Guevara A, Cappa S, et al. Brain Health Services for the secondary prevention of cognitive impairment and dementia: opportunities, challenges, and the business case for existing and future facilities. J Prev Alzheimer’s Dis. In press 2025.
- Giovanni B Frisoni, Emil Aho, Carol Brayne, Olga Ciccarelli, Bruno Dubois, Nick C Fox, et al., Perspectives de la maladie d'Alzheimer : controverses et orientations futures, The Lancet, 2025, Vol. 406, n° 10510, p1424-1442.
